This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Astrazeneca Ab, Kudos Pharmaceuticals Limited. Active years: 2013-2023.
Location History:
- Ludwigshafen, DE (2013)
- Macclesfield, GB (2023)
Company Filing History:
Years Active: 2013-2023
Title: Benedikt Steitz: Innovator in Pharmaceutical Formulations
Introduction
Benedikt Steitz is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, his work focuses on enhancing the bioavailability of pharmaceutical compounds.
Latest Patents
Steitz's latest patents include an immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. This invention relates to a pharmaceutical formulation that comprises the drug in a solid dispersion with a matrix polymer exhibiting low hygroscopicity and high softening temperature, such as copovidone. The formulation aims to provide a daily pharmaceutical dose of the drug while increasing its bioavailability.
Career Highlights
Throughout his career, Benedikt Steitz has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Kudos Pharmaceuticals Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Steitz has collaborated with various professionals in the field, including Michael Karl Bechtold and Claudia Bettina Packhaeuser. These collaborations have further enriched his work and innovations in pharmaceutical formulations.
Conclusion
Benedikt Steitz is a distinguished inventor whose contributions to pharmaceutical formulations have the potential to improve drug delivery and efficacy. His innovative approaches continue to influence the field of pharmaceuticals.